Last update 08 May 2025

McNeil Sweden AB

Subsidiary Company|2006|Sweden|
www.mcneilab.se

Overview

Tags

Respiratory Diseases
Neoplasms
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
Muscle-type nAChRs(Muscle-type nicotinic acetylcholine receptor)1

Related

1
Drugs associated with McNeil Sweden AB
Nicotine
Target
Muscle-type nAChRs
Mechanism
Muscle-type nAChRs agonists
Active Org.
Chattem, Inc.Chattem, Inc. [+8]
Originator Org.
Neuraltus Pharmaceuticals, Inc.Neuraltus Pharmaceuticals, Inc.
Active Indication
Tobacco Use Disorder [+3]
Inactive Indication
Acral Lentiginous Malignant Melanoma [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date13 Jan 1984
1
Clinical Trials associated with McNeil Sweden AB
CTR20170704
/ CompletedNot Applicable
在健康吸烟者中评估尼古丁替代药物和尼古丁咀嚼胶（薄荷味）生物等效性的单次给药、随机四周期空腹交叉研究
[Translation] A single-dose, randomized, four-period fasting crossover study to evaluate the bioequivalence of nicotine replacement products and nicotine chewing gum (mint flavor) in healthy smokers
100 Clinical Results associated with McNeil Sweden AB
Login to view more data
0 Patents (Medical) associated with McNeil Sweden AB
Login to view more data
100 Deals associated with McNeil Sweden AB
Login to view more data
100 Translational Medicine associated with McNeil Sweden AB
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Nicotine
 ( Muscle-type nAChRs )		-
NDA/BLA
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free